01066.HK
Shandong Weigao Group Medical Polymer Company Limited
HKSE · Healthcare · Medical - Instruments & Supplies · CN
HKD 3.23
−2.42%Year over year
Reported trailing growth
- Revenue
- +3.1%
- EBITDA
- -11.9%
- EBIT
- -25.1%
- EPS
- -28.6%
- Free cash flow
- -47.4%
- Operating cash flow
- +5.8%
Forward estimates
Based on analyst estimates
- Revenue
- +7.8%
- EBITDA
- +14.3%
- EPS
- +15.3%
Three-year CAGR
- Revenue
- -0.6%
- EBITDA
- -13.5%
- EBIT
- -16.6%
- Net income
- -16.4%
- EPS
- -16.9%
- Free cash flow
- +16.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026